Nuclear Energy Agency (NEA) – Supporting Britain’s future female nuclear leaders

Nuclear Energy Agency (NEA) – Supporting Britain’s future female nuclear leaders

As component of the Nuclear Power Company (NEA) endeavours to help entice more girls and women into the nuclear power sector, the Company has been co-ordinating worldwide mentoring workshops close to the environment. These workshops provide chances for feminine students to exchange with professionals in the area and emphasize the worthwhile prospects that a job in the science, technological know-how, engineering or mathematics (STEM) fields can supply.

The NEA lately held a mentoring workshop in the United Kingdom at The Institution of Engineering and Engineering in Birmingham on 7-8 March, coinciding with International Women’s Working day.

The workshop was co-organised with the British isles Section for Electrical power Safety and Internet Zero (DESNZ) and Nuclear Abilities Method Group (NSSG). The event aimed to enable aid Britain’s long term woman nuclear leaders and attracted 24 feminine substantial faculty students from 6 faculties in Birmingham and Derby.

NEA Director-General William D. Magwood, IV, attended the workshop and reviewed in his opening remarks why the nuclear sector can not realize success without the need of the participation of extra ladies. Kiera Harper, Deputy Director of Nuclear Electrical power and Sector at the DESNZ highlighted in her address to the students why it is a specifically thrilling time for students to be contemplating a potential job in the UK’s nuclear sector.

Dr Fiona Rayment - UK Mentoring WorkshopDr Fiona Rayment, Chief Science and Technological innovation Officer at the United kingdom Countrywide Nuclear Laboratory and Chair of the NEA Endeavor Team on Increasing Gender Harmony in the Nuclear Sector. 

Dr Fiona Rayment, Main Science and Technologies Officer at the Uk Nationwide Nuclear Laboratory and Chair of the NEA Endeavor Group on Enhancing Gender Balance in the Nuclear Sector, co-chaired the workshop and expended time talking to the pupils about her very own occupation in the nuclear sector. Fellow co-chair, Katharina Stummeter, Head of the Project Management Agency, Gesellschaft für Anlagen- und Reaktorsicherheit (GRS) gGmbH, Germany, also tackled the team and answered  many concerns on what it is like to get the job done in the nuclear sector, as properly as the distinct variety of work opportunities readily available.   

A selection of experienced nuclear experts and leaders acted as mentors at the workshop, like Véronique Rouyer, NEA Elena Neacsu, Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering Suibel Schuppner, Business of Nuclear Vitality, U.S. Department of Vitality Nicole Lee, British isles Frazer-Nash Consultancy Saffron Price tag-Finnerty, The Atmosphere Company, British isles Rhiannon Could, United kingdom Countrywide Nuclear Laboratory and Ronald Clark, Nuclear Techniques Tactic Team, United kingdom.

The workshop attendees obtained more guest talks from Beccy Nice and Rutendo Madhlambudzi from the Nuclear Competencies Method Group, and Georgia Pawson, PA Consulting.

JH 060323 NEA Mentoring 014The British isles mentoring workshop captivated 24 female significant college college students from 6 schools in Birmingham and Derby. 

A unique student-to-student discuss arrived from Grace Stanke, a nuclear engineering student at the University of Wisconsin-Madison and present Pass up The us, who joined the workshop by movie hyperlink for a dialogue with the college students about why she enjoys studying nuclear engineering.

The United Kingdom’s nuclear sector is going through a sizeable transformation. The government’s existing strategy aims for new nuclear capacity to supply about 25{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} of electrical power by 2050, and a modern announcement disclosed that nuclear power is taking one more stage nearer to getting classed as environmentally sustainable in the UK’s inexperienced taxonomy.

This enlargement of the nuclear sector will need the United kingdom to appreciably enlarge the workforce in order to satisfy their formidable nuclear creation targets, the sector desires to bring in extra gals and girls into the nuclear discipline.

The latest condition of gender equilibrium in the nuclear sector was recently highlighted in a new report by the NEA.  

Axxess and SimiTree Release 2023 Trends Report Studying 2023 Agency Strategies in the Care at Home Industry

Axxess and SimiTree Release 2023 Trends Report Studying 2023 Agency Strategies in the Care at Home Industry

Predominant Issues Include Staff Retention and Regulatory Troubles

DALLAS, Jan. 19, 2023 /PRNewswire/ — A latest study of thousands of dwelling-centered care vendors yielded critical insights into strategies and opportunities for corporations in the treatment at house market. An analysis of the study knowledge is now available in the 2023 Field Tendencies Report provided by Axxess, the main know-how innovator for healthcare at dwelling, and SimiTree, a premier provider of remedies for compliance, growth and profitability in the article-acute care sector.

A recent survey of more than 1,800 respondents yielded key insights into the most effectiA recent survey of thousands of home-based care providers yielded key insights into staffing and regulatory challenges in the care at home industry. An analysis of the survey data is now available in the 2023 Industry Trends Report provided by Axxess, the leading technology innovator for healthcare at home, and SimiTree, a premier provider of solutions for compliance, growth and profitability in the post-acu

A new survey of far more than 1,800 respondents yielded crucial insights into the most effectiA recent study of thousands of dwelling-primarily based treatment providers yielded essential insights into staffing and regulatory issues in the care at house marketplace. An investigation of the study knowledge is now offered in the 2023 Sector Trends Report supplied by Axxess, the major technology innovator for healthcare at property, and SimiTree, a leading supplier of methods for compliance, expansion and profitability in the article-acu

Study responses demonstrate businesses continuing to be challenged to do additional with a lot less. Article-pandemic function demand boosts and new regulatory alterations though addressing ongoing staffing challenges are the most important obstacles companies determined in the survey. Best tactics instructed in the report consist of:

  • Enhance margins with operational improvements.

  • Educate and teach your workers.

  • Interact in in-depth payer agreement evaluation in the course of strategic planning

  • Evaluate key techniques that push engagement and retention.

“When our industry is dealing with a selection of worries, this study confirmed that recruitment and retention of staff, as properly as reimbursement rates, are impacting the capability to present high quality treatment,” said Tammy Ross, senior vice president of qualified expert services at Axxess. “Leveraging workers instruction sources and sensible technology to be certain a solid understanding of regulatory changes throughout organizations will be crucial.”

“2023, like any other year, provides its own one of a kind established of problems and alternatives for the house treatment market,” reported Nick Seabrook, controlling principal at SimiTree. “Businesses are continue to working with staffing shortages and regulatory scrutiny that threatens reimbursement rates and patients’ entry to care. Organizations that create and execute a strategic approach to handle the threats and options are the ones that will placement themselves for a effective 2023.”

The 2023 Sector Traits Report contains key insights on particular survey concerns, as perfectly as additional best techniques from Axxess and SimiTree experts to enable businesses generate higher margins and retain team. The report is obtainable to download now.

About Axxess

Axxess is the main know-how innovator for health care at home, offering solutions that help enhance care for additional than 3 million individuals globally. Reliable by extra than 9,000 businesses, Axxess gives a entire suite of straightforward-to-use software answers that empower residence overall health, residence care and hospice suppliers to expand their business enterprise although building lives improved. The company’s collaborative society focused on innovation and excellence is acknowledged nationally as a “Most effective Place to Do the job.”

About SimiTree

SimiTree, a business that presents marketplace-main, tech-enabled specialty income cycle management (RCM), coding, skilled expert services, and expertise management means for post-acute and behavioral wellness businesses, was created by the merger of Simione Health care Consultants and BlackTree Healthcare Consulting in 2021. In 2022, SimiTree additional expanded its RCM capabilities with its Imark Billing acquisition, and its behavioral wellness footprint with a strategic alignment with Infinity, a SimiTree firm.

In addition to scientific, financial, and operational consulting, SimiTree delivers a sturdy suite of outsourced services, including billing, coding, OASIS, Critique Preference Demonstration (RCD) and Top quality Evaluation and Efficiency Improvement (QAPI), and earnings cycle administration govt placement, interim management, retention consulting and other talent methods mergers and acquisitions aid compliance assessments and possibility mitigation programs income and progress teaching and benchmarking and facts analytics. For more data, go to www.SimiTreeHC.com.

Cision

Cision

Watch unique content to down load multimedia:https://www.prnewswire.com/information-releases/axxess-and-simitree-release-2023-trends-report-researching-2023-company-tactics-in-the-care-at-home-marketplace-301725394.html

Source Axxess

US health agency accused of bowing to drug industry with new opioid guidance | Opioids crisis

US health agency accused of bowing to drug industry with new opioid guidance | Opioids crisis

The Centers for Condition Command and Prevention (CDC) has been accused of bowing to drug industry pressure following releasing new recommendations that medical professionals say place life at possibility by rowing again on warnings about the potential risks of opioid prescribing.

The hottest CDC rules have brought about controversy after dropping unique limitations on dosages and lengths of prescribing from a vital summary of tips made use of by doctors.

Dr Kenneth Scheppke, Florida’s deputy wellbeing secretary, was so disturbed he issued a general public assertion accusing the CDC of “tossing aside” the limits utilised in the former rules produced 6 a long time back. Scheppke advised the Guardian he is worried that the shift could cost life as the US carries on to grapple with the worst drug epidemic in its background, pushed by opioids.

“It’s rather crystal clear to me that they soften some actually good, strong tips that they experienced in 2016 warning prescribers versus over prescribing these opioids, and I don’t definitely see a superior reason for removing those two warnings,” he claimed.

“The United States currently has the best per capita opioid prescriptions in the world, and our overdose quantities unquestionably replicate that. My concern is the evident softening of the warning to my colleagues across the nation of the dangers of prescribing either for way too a lot of times or to a better dose. That doesn’t actually aid the pain but raises significantly the threat of overdose and loss of life.”

Dr Andrew Kolodny, president of Doctors for Dependable Opioid Prescribing, sees the drug industry’s hand at the rear of the alter. Kolodny has testified from opioid makers in legal actions in excess of their portion in driving the opioid epidemic by pushing income with fake statements about their basic safety and efficiency.

They include things like Purdue Pharma, company of OxyContin, a impressive narcotic capsule that kickstarted the US’s opioid epidemic together with the company’s marketing approach to see the medicines widely prescribed.

Kolody reported court docket documents exhibit that the drug business calculated how a great deal the 2016 CDC recommendations would price it if health professionals adopted the suggestions to limit prescribing of substantial dosage tablets.

“The highest dosage products have had the optimum financial gain margin. It only charges a couple of excess pennies to make the larger dosage capsule, but retail it is virtually double what they get for each pill or prescription. So the sector fought pretty hard to block the release of the 2016 guideline and when that failed they did every thing they could to make the guidelines show up controversial. And that labored,” he reported.

The most up-to-date CDC recommendations, introduced final month, arrive as the US continues to grapple with tens of hundreds of opioid overdose deaths each individual calendar year, as effectively as the repercussions of addiction for some others hooked on the medication and their households.

The most significant killer today is the powerful artificial opioid, fentanyl, in its illegally made sort. It was connected to the fatalities of much more than 70,000 Us residents very last calendar year. A lot more American adults beneath the age of 45 die from drug overdoses than in the combined toll of motor vehicle mishaps and suicide.

But prescription opioids drove the US opioid epidemic for a lot more than a 10 years, and carry on to declare life.

The CDC’s 2016 pointers have been intended to prevent a lot more People in america from getting addicted to prescription drugs and to stem the circulation toward illicit opioids these kinds of as heroin and fentanyl. They established advisable limitations for dosages and how long opioids must be recommended for.

People limits stay deep in the human body of the newest tips but are excluded from what are known as the “box three recommendations”, a summary of the steering which Scheppke stated is all most doctors examine.

“They won’t get all that excellent track record facts buried in the textual content that details out the scientific realities that dosage previously mentioned a certain level presents minimum advantage, but considerably better hazard of overdose and demise,” he said.

“The 2016 recommendations gave physicians tips saying that if you are prescribing for acute ache for much less than three days which is generally fair. Hardly ever will you need a lot more than 7 days.”

That immediate warning is absent from the tips in the most up-to-date doc.

Scheppke also took challenge with the newest warning that opioids “carry considerable likely risk”.

“There is absolutely nothing potential about it,” he explained, noting that the earlier pointers stated flatly that the hazard existed.

Kolodny reported that from the beginning the drug sector resisted formal curbs on opioid prescribing.

“In 2016, it was specifically significant since the drug business advertising and marketing disguised as professional medical education and learning for a lot of several years experienced pushed this notion that there’s no upper dose limit on opioids, that you must just go as higher as any one requirements. So it was truly essential,” explained Kolodny.

“That upper dosage limit in the 2016 guideline was what was most concerning to business.”

In 2018, Senator Claire McCaskill launched a report detailing how opioid producers put in thousands and thousands of dollars funding entrance groups, together with to oppose the primary CDC guidelines. Purdue Pharma gave $500,000 to the Washington Lawful Foundation, which beforehand defended the tobacco field, to launch a court problem to them.

Kolodny reported that when that didn’t operate, the opioid market attacked the CDC pointers by expressing they ended up driving clients to suicide due to the fact doctors have been depriving clients of opioids and forcing them to dwell with unbearable agony.

Equally Scheppke and Kolodny concern that declare although acknowledging that there is a very authentic challenge of sufferers who ended up dependent on significant dosages of opioids who involve treatment for dependency and withdrawal. Kolodny reported that drove some in withdrawal to kill on their own but the drug industry has made use of entrance teams to overstate the quantity of deaths and to spin them as a consequence of absence of soreness procedure in a bid to force the CDC to rest its pointers.

“This is a truly serious issue. But what the opioid advocates, lots of with market ties, disclosed or undisclosed, pushed was this untrue narrative about an epidemic of suicide and so there was a manufactured backlash in opposition to the CDC guidelines,” he claimed.

“The notion that there are patients shedding obtain to an effective procedure, and hence they have no option but to get rid of on their own simply because they are in so significantly discomfort now, which is a hoax. But the thought that an individual in the context of acute withdrawal would kill themselves, that undoubtedly could be real since it’s so excruciating.”

Scheppke explained that what is essential is not weakened prescribing tips but greater treatment for men and women dependent on opioids.

The CDC has been contacted for comment.